Hyperlipidemia: Management with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors
M. Shahreyar, Salem A. Salem, Mannu Nayyar, Lekha K. George, N. Garg, S. Koshy
Journal of the American Board of Family Medicine